Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Entospletinib effectively prevents eye and skin GVHD in mice.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

PTH-CBD agonists may help regrow hair after chemotherapy.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Provenge extends prostate cancer survival by about 4 months.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Activated protein C helps protect mice from long-term radiation damage.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Promising cancer treatments were found, but the manufacturer closed.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.